Basilea Pharmaceutica AG (BSLN.SW) - Stock Prices, Stock Peers & Analysis

Home
BSLN.SW

Company Name	Basilea Pharmaceutica AG
Symbol	BSLN.SW
Currency	CHF
Price	45.25
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	548,478,237
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	32 - 48.55
Industry	Biotechnology
Sector	Healthcare
CEO	Mr. David Veitch
Website	https://www.basilea.com

An error occurred while fetching data.

About Basilea Pharmaceutica AG

Basilea Pharmaceutica AG, a commercial stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. It offers Cresemba, an intravenous and oral azole antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and